Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
US8846945B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Inventors
Key dates
| Filing date | May 2, 2012 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | May 2, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula I:or a pharmaceutically acceptable salt thereof, wherein, R1 is optionally substituted tetrazolyl, R2 is optionally substituted phenyl, optionally substituted pyridinyl or optionally substituted thienyl, and R3, R4, R5 and R6 are as defined herein. Also provided are methods of using the compounds for treating diseases associated with the P2X3 and/or a P2X2/3 receptor antagonist and methods of making the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.